Advertisement
Canada markets open in 1 hour 59 minutes
  • S&P/TSX

    22,465.37
    +165.57 (+0.74%)
     
  • S&P 500

    5,308.13
    +4.86 (+0.09%)
     
  • DOW

    39,806.77
    -196.82 (-0.49%)
     
  • CAD/USD

    0.7340
    -0.0002 (-0.03%)
     
  • CRUDE OIL

    78.45
    -1.35 (-1.69%)
     
  • Bitcoin CAD

    97,032.17
    +5,465.23 (+5.97%)
     
  • CMC Crypto 200

    1,534.96
    +46.42 (+3.12%)
     
  • GOLD FUTURES

    2,421.90
    -16.60 (-0.68%)
     
  • RUSSELL 2000

    2,102.50
    +6.78 (+0.32%)
     
  • 10-Yr Bond

    4.4370
    +0.0170 (+0.38%)
     
  • NASDAQ futures

    18,751.25
    -11.75 (-0.06%)
     
  • VOLATILITY

    12.43
    +0.28 (+2.31%)
     
  • FTSE

    8,388.63
    -35.57 (-0.42%)
     
  • NIKKEI 225

    38,946.93
    -122.75 (-0.31%)
     
  • CAD/EUR

    0.6751
    -0.0005 (-0.07%)
     

CooperCompanies Announces Release Date for Second Quarter 2024

CooperCompanies
CooperCompanies

SAN RAMON, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report second quarter 2024 financial results on Thursday, May 30, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

The dial-in number for the call is 800-715-9871 and the conference ID is 1712676. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com.

About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women’s health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies (“Cooper”) has a workforce of more than 15,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com.

Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com